SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-292782
Filing Date
2011-11-02
Accepted
2011-11-02 16:15:43
Documents
3
Period of Report
2011-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d249924d8k.htm 8-K 13571
2 PRESS RELEASE d249924dex991.htm EX-99.1 122291
3 GRAPHIC g249924ex99_1pg001.jpg GRAPHIC 7302
  Complete submission text file 0001193125-11-292782.txt   147487
Mailing Address 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12276 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 111174633
SIC: 2836 Biological Products, (No Diagnostic Substances)